About
Provided by Herbert Smith Freehills Kramer LLP
Herbert Smith Freehills Kramer is a leading global law firm with over 6,000 people, including 630 partners, in 26 offices across Africa, Asia, Australia, Europe, the Middle East and the US. We offer local insight and seamless cross-border service in all major regions.
Our global pharmaceuticals and healthcare team combines scientifically qualified leaders in their fields with the platform and resources of an elite global firm, giving our clients access to a broad range of high quality, commercially nuanced, sector-focused insight wherever they need it.
We have a proven track record in helping pharmaceuticals and life science clients across the entire product life cycle, from seed financing to BD transactions, launch strategy, patent protection, product lifecycle management (antitrust), M&A, financing, merger control and regulatory matters – with our UK team often coordinating matters globally, most notably in commercial litigation/arbitration, M&A, competition and patent litigation and strategy.
As a firm, we are committed to investing in our expertise in the pharmaceuticals and life sciences sector, and our internal organisation reflects this commitment. We have a global pharmaceutical steering group, tasked with ensuring our specialism in this sector continues to develop and that as a firm we are equipped to assist our clients with their most important matters and emerging themes.
